Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 4 of 27 | Showing Results 16 - 20 of 135

A Multi-Center Prospective Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy

Inclusion Criteria:• Subject is 18 years or older• Subject undergoing either laparoscopic or robotic-assisted right colectomy for benign or...

Amir Bastawrous, M.D.
  • Swedish Medical Center

SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer

Inclusion Criteria:• Histologically proven adenocarcinoma of the prostate• Evidence of metastasis by magnetic resonance imaging (MRI)/computed...

James Porter, M.D.
  • Swedish Medical Center

A Phase 2, Open-Label, 2-Arm, Response Rate Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer Who Previously Received Taxane-Based Chemotherapy and Progressed on at Least 1 Novel Hormonal Agent (Enzalutamide and/or Abiraterone Acetate/Prednisone)

A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer.Inclusion Criteria:• Histologically or...

Song Zhao, M.D.
  • Swedish Medical Center

SHS 492453 ZHAS CPFI 18103 - A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Inclusion Criteria:Histologically or cytologically confirmed adenocarcinoma of the prostate withoutsmall cell or signet cell featuresAsymptomatic...

Song Zhao, M.D.
  • Swedish Medical Center

RNS System Post-Approval Study in Epilepsy

The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data...

Ryder Gwinn, M.D.
  • Swedish Medical Center
Viewing Page 4 of 27 | Showing Results 16 - 20 of 135